Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medipharm Labs Corp (OP: MEDIF )

0.0500 +0.0001 (+0.20%)
Streaming Delayed Price Updated: 3:06 PM EDT, Jul 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Medipharm Labs Corp

< Previous 1 2 3 4 Next >
Marijuana Stock Movers For August 2, 2023
Via Benzinga
MediPharm Delivers Cannabis Clinical Trial Material To US Research Partner And Provides Update On FDA Status
MediPharm Labs Corp. (OTCQB: MEDIF) (TSX:LABS) (FSE:MLZ) has made its first delivery to the United States, and has completed the US FDA drug API manufacturer inspection at the company's Barrie, Ontario... 
Via Benzinga
Cannabis Stock Gainers And Losers From July 25, 2023
Via Benzinga
Marijuana Stock Movers For August 1, 2023
Via Benzinga
Leadership Shake-Ups Across Several Weed Companies: Who Got The Top Jobs?
As Benzinga Cannabis Capital Conference returns to Chicago this Sept 27-28 for its 17th edition, gathering top CEOs, investors and leaders in the marijuana 
Via Benzinga
MediPharm Labs Awarded Payment Of $9.8M By Ontario Court Of Justice
MediPharm Labs Corp. 
Via Benzinga
Cannabis Stock Movers For July 24, 2023
Via Benzinga
Two Pot Companies Continue To Focus On Cannabinoid-Based Self-Emulsifying Drug Delivery Systems
Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN) announced the extension of its existing strategic manufacturing agreement with Medipharm Labs Inc. (OTCQB: MEDIF) for the commercialization of... 
Via Benzinga
The Canadian Cannabis Report - Monday, May 22
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 16 stocks. 
Via Talk Markets
Cannabis Stock Movers For July 20, 2023
Via Benzinga
MediPharm Labs Corp. Q1 Revenue Grows 20% YoY, Achieves First Quarter Of Positive Adjusted EBITDA
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced financial results for Q1 2023, revealing EBITDA growth over the past two years and a significant reduction in losses to CA$2.1... 
Via Benzinga
The Canadian Cannabis Report - Monday, April 14
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks. 
Via Talk Markets
MediPharm Labs Begins Restructuring Following Acquisition Of VIVO, Reduces Non-Direct Labor Workforce By ~30%
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) provided an update on progress made on the integration of VIVO Cannabis Inc.'s (OTCQB: VVCIF) operations follow 
Via Benzinga
The Canadian Cannabis Report - Monday, April 10
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 17 stocks. 
Via Talk Markets
MediPharm Labs FY22 Revenue Grows Slightly To $16.3M
MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) FY 2022 revenue was CA$22.1 million ($16.3 million), an increase of 1.8% compared to CA$21.7 million in FY 2021. 
Via Benzinga
MediPharm Labs Shareholders Approve Merger With VIVO Cannabis
MediPharm Labs Corp. 
Via Benzinga
Historic Ruling To Legalize Cannabis Cultivation In Brazil: These Weed Companies Will Likely Benefit
Following years of stalling on the issue of legal cultivation of cannabis for medicinal and industrial purposes, a Brazilian appeals court is set to rule on allowing businesses and farmers to... 
Via Benzinga
MediPharm Labs To Acquire VIVO Cannabis
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE: MLZ) and VIVO Cannabis Inc. 
Via Benzinga
MediPharm Labs Corp. to Acquire VIVO Cannabis Inc.
Two global leaders in the medical wellness cannabis industry expected to combine complementary strengths of diversified revenue in multiple markets... 
Via Newsfile
Topics Cannabis
Exposures Cannabis
The Canadian Cannabis Report - Monday, Dec. 19
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Nov.28
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 21 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Nov. 21
The past, present and future of the Canadian cannabis sector, based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
MediPharm Touts Strong Q3 Revenue Growth, Continues To Expand Internationally
MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced on Monday its financial results for the three months ended Sept. 30, 2022. 
Via Benzinga
The Canadian Cannabis Report - Monday, Nov. 14
The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Aug. 29
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, Aug. 15
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
MediPharm Labs Q2 Revenue Declines 14% YoY, Here Are The Details
MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021. 
Via Benzinga
The Canadian Cannabis Report - Monday, Aug. 1
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
The Canadian Cannabis Report - Monday, July 25
The past, present and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 22 stocks. 
Via Talk Markets
MediPharm Labs Enters Into $4.68M Purchase Agreement For The Sale Of Australian Facility
MediPharm Labs Corp. 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.